Inventor · disambiguated record
Ami M. Kabadi
Also filed as: KABADI AMI · KABADI AMI M · KABADI AMI MEDA
4 granted patents·5 pending applications·73 citations·filing 2014–2025
76Inventor score
Files withUNIV DUKE3VERTEX PHARMA3CRISPR THERAPEUTICS AG1SAREPTA THERAPEUTICS INC1UCB Biopharma SRL1
Top patents by PatentIndex Score
9 records- 0194US10745714B2RNA-guided gene editing and gene regulationUNIV DUKE·Filed 2018·Granted Aug 18, 2020·21 cites·17 claims
- 0294US10704060B2RNA-guided gene editing and gene regulationUNIV DUKE·Filed 2014·Granted Jul 7, 2020·51 cites·10 claims
- 0382US2025064980A1Materials and Methods for Treatment of Duchenne Muscular DystrophyVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0478US12053531B2Materials and methods for treatment of Duchenne Muscular DystrophyVERTEX PHARMA·Filed 2022·Granted Aug 6, 2024·0 cites·5 claims
- 0578US11369692B2Materials and methods for treatment of Duchenne Muscular DystrophyVERTEX PHARMA·Filed 2016·Granted Jun 28, 2022·1 cites·3 claims
- 0664US2021002665A1Rna-guided gene editing and gene regulationUNIV DUKE·Filed 2020·Application pending·0 cites
- 0754US2023295657A1Gene therapy using nucleic acid constructs comprising methyl cpg binding protein 2 (mecp2) promoter sequencesUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 0853US2025360228A1Treatment of genetic neurological conditions with genomic editingSAREPTA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0943US2021260219A1Materials and methods for treatment of amyotrophic lateral sclerosis and/or frontal temporal lobular degenerationCRISPR THERAPEUTICS AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ami M. Kabadi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →